Clinical Trials in Ohio

Showing 11181-11200 of 17,983 trials

Answer ALS: Individualized Initiative for ALS Discovery

NCT02574390

Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons

Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more

Johns Hopkins University1,049 participantsStarted Dec 2015

Los Angeles, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 1/232 miles

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

NCT00002602

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have previously untreated stage II or stage III prostate cancer.

Prostate Cancer

Radiation Therapy Oncology Group1,084 participantsStarted May 1994

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +225 more locations

Answer ALS: Individualized Initiative for ALS Discovery

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Find Trials by Condition in Ohio

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Performance Assessment of a Modified Daily Disposable Contact Lens

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

Safety of PDT-Photofrin® Prior to Lung Surgery

A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

Radiesse® Safety Study For the Treatment of Hands

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia